But alongside these celebrated benefits, a more complicated conversation has started to surfaceone that isnt about body fat, blood sugar, or the number on the scale
Professor David Attwell, Jodrell Professor of Physiology at UCL, and the study's co-lead, added: "With an increasing number of similar GLP-1 drugs now being used in clinical practice, for conditions ranging from type 2 diabetes and obesity to kidney disease, our findings highlight the potential for these existing drugs to be repurposed to treat the risk of 'no-reflow' in heart attack patients, offering a potentially life-saving solution." Dr
If you experience any of these symptoms, seek medical attention promptly
Self-funded employer plans (where the employer pays claims directly rather than buying insurance) are regulated by federal law, not state law, so state mandates often don't apply to them